Schlagwörter
Netherlands
3
apixaban
3
QUALITY-OF-LIFE
2
acenocoumarol
2
adult
2
aged
2
article
2
controlled study
2
cost effectiveness analysis
2
cost-effectiveness
2
drug cost
2
female
2
human
2
male
2
phenprocoumon
2
quality adjusted life year
2
venous thromboembolism
2
ACUTE PULMONARY-EMBOLISM
1
Adolescents
1
Adult
1
Age Factors
1
Aged
1
Attention-deficit/hyperactivity disorder
1
CHILDHOOD PREDICTORS
1
CLINICAL-COURSE
1
Cardiovascular Diseases
1
Children
1
Cost of illness
1
Cost-Benefit Analysis
1
DEEP-VEIN THROMBOSIS
1
DEFICIT-HYPERACTIVITY-DISORDER
1
Databases
1
Diabetes Mellitus
1
EXCESS COSTS
1
EXTENDED TREATMENT
1
Factual
1
Female
1
Humans
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
Male
1
Markov Chains
1
Medication Adherence
1
Middle Aged
1
NCT00412984
1
NCT00496769
1
POPULATION
1
PREVALENCE
1
Primary Prevention
1
Quality-Adjusted Life Years
1
REGISTRY
1
weitere ...